Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest Pharmaceuticals

21:00 BST Norgine Announces FDA Filing Acceptance for PLENVU® (NER1006)

Launch date set for first quarter 2018 Norgine B.V. today announced that it has received acceptance from the US Food and Drug Administration...


14:45 BST Global Hepatitis Drug Market & Clinical Trials Insight 2023: Introduction of Generic Drugs Has Changed Market Dynamics

Research and Markets has announced the addition of the "Global Hepatitis Drug Market & Clinical Trials Insight 2023" report to their offering....


13:00 BST GenePOC Announces an Exclusive Distribution Agreement with Cardinal Health Covering the US Market

GenePOC announces the signing of an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States...


13:00 BST Global Active Pharmaceutical Ingredient (API) Market is Estimated to Reach US$ 225.2 Bn by 2025 - PMR New Report

A new study conducted by Persistence Market Research reveals that the US$ 151.9 Bn global active pharmaceutical ingredient market will grow to...


09:00 BST Johannesburg Conference to Tackle Digital Transformation in Healthcare

The 3rd Healthcare Innovation Summit Africa (#HISA2017), taking place in Johannesburg on 29-30 August 2017, will tackle hot topics such as robotic...


08:00 BST Heptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine

New programme focused on key GPCR target implicated in aggressive brain cancer Heptares Therapeutics ("Heptares"), the wholly-owned subsidiary...


27 Jun, 2017, 14:30 BST Diabetic Neuropathy Market to Reach US$5.718 Billion by 2024: Players Focus on Drug Development to Bolster Positions

The Global Diabetic Neuropathy Market is semi-consolidated in which the prominent players hold limited share. The competition among the existing...


27 Jun, 2017, 13:45 BST CBD Based Products Fueling Cannabis Industry Revival

The growing legal changes in the U.S. and Canada were approved at some level of marijuana operations for both medicinal and recreational use, as...


27 Jun, 2017, 13:30 BST Global Medication Dispenser Market to Reach US$ 1,824.7 Mn by 2025 - Latest Report by PMR

Factors as such are anticipated to support the growing use of medication dispenser in ambulatory surgical centers, hospitals and nursing homes....


27 Jun, 2017, 12:15 BST MEA Parenteral Nutrition Market Analysis and Segment Forecasts, 2014-2017 & 2025 - Single Dose Amino Acid Solutions Held a Dominant Share in 2016 - Research and Markets

Research and Markets has announced the addition of the "MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral...


27 Jun, 2017, 12:00 BST Visceral Pain Market Size to Reach USD 14.22 Billion by 2024: Hexa Research

The global visceral pain market is expected to reach USD 14.22 billion by 2024, driven by the increasing geriatric population globally. Increasing...


27 Jun, 2017, 10:00 BST NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market,...


27 Jun, 2017, 06:47 BST Sanofi Announces Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union

- Marketing authorisation for sarilumab offers a new treatment option for people in Ireland living with the debilitating effects of RA...


27 Jun, 2017, 06:45 BST Sanofi Announces Licensing of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union

- Marketing authorisation for sarilumab offers a new treatment option for people in the UK living with the debilitating effects of RA - Sanofi...


26 Jun, 2017, 20:13 BST MYM Interviewed by CBC National News Today on Weedon Project

MYM Nutraceuticals Inc. (CSE: MYM) (OTC:MYMMF), is extremely pleased to announce that CBC National News is featuring MYM's new Weedon Greenhouse,...


26 Jun, 2017, 14:15 BST Global Ophthalmic Drugs Market Forecast 2017-2027

Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs The global ophthalmic drugs market is expected...


26 Jun, 2017, 13:30 BST Biotech Stocks Showing Signs of Resurgence

The Nasdaq Biotechnology Index (NBI) surged last week as Research and Development for the advancement of rare cancer therapies and anti-cancer...


26 Jun, 2017, 13:15 BST Pharmaceutical Pipeline Innovation and Clinical Trial Tracking Factbook 2017 - Research and Markets

Research and Markets has announced the addition of the "Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical...


26 Jun, 2017, 13:00 BST Merck adds Chemical Products to Reaxys' Chemistry Database

- Allows customers to easily find, procure products in the Reaxys inventory - Reduces barriers for customers to develop new chemistries,...


26 Jun, 2017, 11:30 BST Data Provide Additional Insight Into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients With Relapsing MS

- Data suggest that MAVENCLAD™ (Cladribine Tablets) selectively and discontinuously reduces B and T lymphocytes, with lymphocyte...


24 Jun, 2017, 18:17 BST Merck to Present Data on MAVENCLAD™ (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017

- New data builds on company's longstanding commitment to MS Merck, a leading science and technology company, will present data...


24 Jun, 2017, 07:30 BST European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive non-Hodgkin Lymphoma (NHL)

Outcomes for patients with refractory, aggressive non-Hodgkin lymphoma (NHL) are poor with current therapies. Axicabtagene ciloleucel (axi-cel)...


24 Jun, 2017, 07:30 BST European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: An Interim Analysis of the JULIET Study

CTL019 consists of genetically engineered autologous T cells expressing a chimeric antigen receptor (CAR). Results from a prior single-center...


24 Jun, 2017, 07:30 BST European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity in Patients with Advanced Stage Hodgkin Lymphoma: the GHSG HD18 Study

Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with eight or six cycles of eBEACOPP is very effective in...